PUBLIC CONTRACT · 2026
Aquisição de DEGARRELIX SC 80MG PO SOL INJ, ao abrigo do AQ 2026/6, para a ULSASI, para o ano de 2026
- Contract value
- €6,069.80
- Signed on
- 7 October 2026
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15737599PUBLISHED SUBJECT
Aquisição de DEGARRELIX SC 80MG PO SOL INJ, ao abrigo do AQ 2026/6, para a ULSASI, para o ano de 2026
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- PT1A0 - Grande Lisboa
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- CENCORA 3PL PORTUGAL, S.A. · Tax ID 503934640
Values and timeline
- Contract price
- €6,069.80
- Procedure base price
- €6,069.80
- Total effective price
- Not reported on Portal BASE
- Publication date
- 7 October 2026
- Award date
- 2 October 2026
- Signing date
- 7 October 2026
- Performance period
- 85 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 2026/6 - Acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11610048
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.